Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

SHPG:US

240.9700 USD 2.4700 1.04%

As of 16:30:00 ET on 03/27/2015.

Snapshot for Shire PLC (SHPG)

Open: 239.6900 Day's Range: 238.9900 - 243.1100 Volume: 498,585
Previous Close: 238.5000 52wk Range: 141.6600 - 264.9800 1-Yr Rtn: +59.72%

Stock Chart for SHPG

No chart data available.
  • SHPG:US 240.9700
  • 1D
  • 1M
  • 1Y
238.5000
Interactive SHPG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SHPG

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 21.3361
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) 11.2940
Est. PEG Ratio 1.7169
Market Cap (M USD) 47,410.61
Shares Outstanding (M) 196.75
30 Day Average Volume 634,780
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.48%
Cash Dividend (USD) 0.5727
Dividend Ex-Date 03/11/2015
5 Year Dividend Growth 15.00%
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SHPG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SHPG

Shire PLC markets, licenses and develops prescription medicines. The Group focuses its operations on attention deficit and hyperactivity disorders, human genetic therapies, gastrointestinal, and renal diseases.

Flemming OrnskovChief Executive OfficerJeff PoultonInterim CFO/Head:Investor Relations
Ginger GregoryChief Human Resources OfficerMark J EnyedyHead:Corporate Development
More Company Profile & Key Executives for SHPG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil